Contraindicated in:
Use Cautiously in:
Derm: rash.
GI: diarrhea, abdominal pain, ↓ appetite, dyspepsia, gastritis, nausea, vomiting.
Metab: weight loss.
MS: muscle spasms.
Neuro: tremor , SUICIDAL THOUGHTS/BEHAVIOR, anxiety, depression, dizziness, headache, insomnia.
Drug-Drug:
Absorption: Well absorbed following oral administration.
Distribution: Parent drug and metabolites probably enter breast milk.
Protein Binding: Roflumilast 99%; roflumilast N-oxide 97%.
Metabolism/Excretion: Mostly metabolized (87.5%), primarily by CYP3A4 and CYP1A2 enzyme systems One metabolite, roflumilast N-oxide in pharmacologically active. Inactive metabolites excreted in urine.
Half-life: Roflumilast 17 hr; roflumilast N-oxide 30 hr.
NDC Code*